PDF(Pubmed)
Abstract：
Peripartum cardiomyopathy is a rare life-threatening condition occurring in previously healthy women with symptoms mimicking those of normal pregnancy and is associated with a high mortality rate. A high index of suspicion coupled with a sound understanding of the disease is crucial to correctly diagnose and manage the patients to improve final maternal outcomes. In this report, we present a total of five cases of peripartum cardiomyopathy in women aged 22 to 38 years who presented between 3 and 21 days postpartum. All patients presented with severely reduced ejection fractions indicative of heart failure and were immediately admitted to our facility. A timely diagnosis was made and patients started on a combination of antibiotics, anticoagulants, and anti-heart failure medication. Despite the severity of the disease upon presentation, early diagnosis and precise management of the disease were essential in achieving favorable patient outcomes. Therefore, this report provides crucial knowledge about the presentation and progression of peripartum cardiomyopathy and presents a treatment protocol from a Kenyan perspective that was successfully employed in the management of all five cases.
摘要：
围产期心肌病是一种罕见的危及生命的疾病，发生在以前健康的女性中，症状模仿正常妊娠的症状，并与高死亡率相关。高度的怀疑指数以及对疾病的良好理解对于正确诊断和管理患者以改善最终的产妇结局至关重要。在这份报告中,我们报告了5例围产期心肌病患者,年龄在22~38岁,产后3~21天.所有患者的射血分数严重降低，表明心力衰竭，并立即入院。及时做出诊断，患者开始使用抗生素组合，抗凝剂,和抗心力衰竭药物。尽管出现时疾病的严重性，疾病的早期诊断和精确治疗对于获得良好的患者结局至关重要.因此,本报告提供了有关围产期心肌病的表现和进展的重要知识,并从肯尼亚的角度提出了一种治疗方案,该方案已成功用于所有5例病例的治疗.
